Mitochondrial Disease: Advances in Clinical Diagnosis, Management, Therapeutic Development, and Preventative Strategies

@article{Muraresku2018MitochondrialDA,
  title={Mitochondrial Disease: Advances in Clinical Diagnosis, Management, Therapeutic Development, and Preventative Strategies},
  author={C. C. Muraresku and E. McCormick and M. Falk},
  journal={Current Genetic Medicine Reports},
  year={2018},
  volume={6},
  pages={62-72}
}
Purpose of ReviewPrimary mitochondrial disease encompasses an impressive range of inherited energy deficiency disorders having highly variable molecular etiologies as well as clinical onset, severity, progression, and response to therapies of diverse multi-system manifestations. Significant progress has been made in primary mitochondrial disease diagnostic approaches, clinical management, therapeutic options, and preventative strategies that are tailored to major mitochondrial disease… Expand
The history and evolving paradigm for genomic diagnosis of mitochondrial diseases
TLDR
This chapter provides a brief overview of some of the pros and cons of different diagnostic approaches and the challenges in establishing robust gene-disease and variant-Disease associations, including detection, prioritization, classification, and validation of genomic variants. Expand
Mitochondrial disease genetics update: recent insights into the molecular diagnosis and expanding phenotype of primary mitochondrial disease
TLDR
Broad-based exome sequencing has become the standard first-line diagnostic approach for PMD diagnosis and continues to improve diagnostic yield, advance understanding of mitochondrial physiology, and provide strong potential to develop precision therapeutics targeted to diverse aspects of mitochondrial disease pathophysiology. Expand
The Diagnostic Approach to Mitochondrial Disorders in Children in the Era of Next-Generation Sequencing: A 4-Year Cohort Study
TLDR
The findings of this study corroborate previous data supporting a role for neuroimaging in the diagnostic approach to MDs and reinforce the idea that mtDNA sequencing should be considered for first-line testing, at least in specific groups of children. Expand
The neuro-ophthalmology of inherited myopathies.
TLDR
Genetic advances are driving progress in the field of inherited myopathies, influencing diagnosis, understanding of disease and development of therapies, and improved understanding of molecular mechanisms in inheritedMyopathies is enabling the development of experimental molecular therapies with clinical potential. Expand
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease.
TLDR
Overall, data suggest cysteamine bitartrate may hold therapeutic potential in RC disease, although not through obvious modulation of total glutathione levels, which is required in clinical trials of human subjects with primary mitochondrial RC disease. Expand
Combinatorial glucose, nicotinic acid and N-acetylcysteine therapy has synergistic effect in preclinical C. elegans and zebrafish models of mitochondrial complex I disease
TLDR
Overall, these data provide objective preclinical evidence in two evolutionary-divergent animal models of mitochondrial complex I disease to demonstrate that combinatorial Glu’+ NA +’NAC therapy significantly improved animal resiliency, even in the face of stressors that cause severe metabolic deficiency, thereby preventing acute neurologic and biochemical decompensation. Expand
Neuroligin-mediated neurodevelopmental defects are induced by mitochondrial dysfunction and prevented by lutein in C. elegans
TLDR
It is shown lutein exerts its beneficial effects by restoring neuroligin expression independently from its antioxidant activity, thus pointing to a possible novel pathogenetic target for the human disease. Expand
Mitochondrial Disease Genes Compendium: connecting with knowledge in the Mitochondrial Disease Sequence Data Resource (MSeqDR)
TLDR
This book will aid clinicians in the search for a differential diagnosis or when seeking to better understand the specific implications of the precise genetic diagnosis their patient has received, and will serve as a generally approachable companion to gain access to the more comprehensive set of highly detailed data and informatics resources available in the Mitochondrial Disease Sequence Data Resource. Expand
Diagnostic genetic testing for patients with bilateral optic neuropathy and comparison of clinical features according to OPA1 mutation status
TLDR
The prevalence and spectrum of mutations in a group of patients referred for genetic testing to a tertiary center in the United States and the clinical features of patients with and without mutations in OPA1, the gene most commonly involved in dominantly inherited optic atrophy were compared. Expand
Landscape of Germline and Somatic Mitochondrial DNA Mutations in Pediatric Malignancies.
TLDR
This pan-cancer mtDNA study establishes the landscape of germline and tumor mt DNA mutations and identifies hotspots of tumor mtDNA mutations to pinpoint key mitochondrial functions in pediatric malignancies and suggests that deleterious mtDNA mutated play a role in the development and progression of pediatric cancers. Expand
...
1
2
...

References

SHOWING 1-10 OF 80 REFERENCES
The in-depth evaluation of suspected mitochondrial disease.
TLDR
The aim of this work is to facilitate the diagnosis of mitochondrial disease by geneticists, neurologists, and other metabolic specialists who face the challenge of evaluating patients of all ages with suspected mitochondrial disease. Expand
Mitochondrial Disease: A Practical Approach for Primary Care Physicians
TLDR
Greater familiarity among primary care physicians with the protean manifestations of mitochondrial disease will facilitate the proper diagnosis and management of this growing cohort of pediatric patients who present across all specialties. Expand
Novel reproductive technologies to prevent mitochondrial disease
TLDR
This review will interrogate the different NT techniques, including a discussion on the available safety and efficacy data of these technologies for mtDNA disease prevention, and appraise the evidence for the translational use of NT technologies in infertility. Expand
Mitochondrial disorders and the eye
TLDR
Understanding of mitochondrial dysfunction has unleashed a range of emerging therapeutic approaches for mitochondrial-based ophthalmologic disorders directed at optimizing mitochondrial function, including therapies that inhibit mitochondrial function and induce apoptosis within tumor cells. Expand
Endocrine Disorders in Primary Mitochondrial Disease
TLDR
Age-specific prevalence of diabetes mellitus (DM), abnormal growth and sexual maturation (AGSM), hypoparathyroidism, and hypothyroidism are measured to reflect the substantial prevalence of endocrine disorders in mitochondrial disease. Expand
New treatments for mitochondrial disease—no time to drop our standards
TLDR
Recommendations are made for the design of future treatment trials in mitochondrial diseases that should no longer rely on potentially biased data, with the associated costs and risks. Expand
Mitochondrial Genomics: A Complex Field Now Coming of Age
TLDR
Gene and mutation-based disease categorization has proven particularly useful to identify the full clinical spectrum of disease that may affect a given individual, and extensive genomic advances have facilitated dramatic improvement in the accurate recognition and understanding of primary mitochondrial disease. Expand
Neurodevelopmental Manifestations of Mitochondrial Disease
  • M. Falk
  • Medicine
  • Journal of developmental and behavioral pediatrics : JDBP
  • 2010
TLDR
A general overview of the current diagnostic evaluation that can be readily initiated by the Developmental Pediatrician is provided, along with a summary of currently available treatment options. Expand
Treatable mitochondrial diseases: cofactor metabolism and beyond.
TLDR
Among the group of these ‘treatable mitochondrial diseases’, defects of cofactor metabolism play a major role and there are several mitochondrial defects that are amendable by specific treatment strategies. Expand
A modern approach to the treatment of mitochondrial disease
TLDR
It is not yet proven that these therapies truly alter the course of the disease, and some experts may choose not to use these medications, but based on clinical experience and judgment, the evidence of their effectiveness does not rise to the level required for universal use. Expand
...
1
2
3
4
5
...